Saltar al contenido
Merck

159530

Sigma-Aldrich

2-Bromo-4′-methylacetophenone

90%

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
CH3C6H4COCH2Br
Número de CAS:
Peso molecular:
213.07
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

assay

90%

bp

105 °C/0.1 mmHg (lit.)

mp

45-49 °C (lit.)

storage temp.

2-8°C

SMILES string

Cc1ccc(cc1)C(=O)CBr

InChI

1S/C9H9BrO/c1-7-2-4-8(5-3-7)9(11)6-10/h2-5H,6H2,1H3

InChI key

KRVGXFREOJHJAX-UHFFFAOYSA-N

General description

2-Bromo-4′-methylacetophenone is an α-bromoketone.

Application

2-Bromo-4′-methylacetophenone was used in the general fluorous thiol quenching method. It was also used in the preparation of hydroxyquinolinone and N-derivatized carboxamides.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Miroslav Soural et al.
Journal of combinatorial chemistry, 9(5), 793-796 (2007-08-07)
A highly efficient solid-phase synthesis of 2-substituted-3-hydroxy-4(1H)-quinolinone-7-carboxamides was developed using anthranilates and bromoketones as the key synthons. Primary amines immobilized to an acid-cleavable BAL linker were acylated with 1-methyl-2-aminoterephtalate. After cleavage of the methyl ester, bromoketones were used to form
Use of fluorous silica gel to separate fluorous thiol quenching derivatives in solution-phase parallel synthesis
Zhang W, et al.
Tetrahedron, 58(20), 3871-3875 (2002)
Hana Elshaflu et al.
Frontiers in chemistry, 6, 247-247 (2018-07-19)
The novel approach in the treatment of complex multifactorial diseases, such as neurodegenerative disorders and cancer, requires a development of efficient multi-targeting oriented drugs. Since oxidative stress significantly contributes to the pathogenesis of cancer and neurodegenerative disorders, potential drug candidates

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico